Drug
Trenibotulinumtoxine And Onabotulinumtoxina
Trenibotulinumtoxine And Onabotulinumtoxina: highest development phase Phase 2, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| TrenibotulinumtoxinE and OnabotulinumtoxinA NCT07871513 | Phase 2 | Upper Facial Lines |
Latest
No recent events.
Follow Trenibotulinumtoxine And Onabotulinumtoxina on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.